550997-55-2

Basic information

• Product Name: 1-Naphthalenecarbonitrile, 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxy-
• CAS NO: 550997-55-2
• Molecular Formula: C17H10FNO2
• Molecular Weight: 279.27
• Mol File: 550997-55-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-Naphthalenecarbonitrile, 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Naphthalenecarbonitrile, 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxy-(550997-55-2)
• EPA Substance Registry System: 1-Naphthalenecarbonitrile, 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxy-(550997-55-2)

Safety Data

• Hazardous Substances Data: 550997-55-2(Hazardous Substances Data)

Usage

Molecular Structure

The compound consists of a naphthalene ring with a cyano group attached at the first position, as well as hydroxyl and fluoro-hydroxyl groups attached at the third and seventh positions, respectively.

Classification

It belongs to the class of naphthalenes, which are polycyclic aromatic hydrocarbons.

Potential Applications

The compound may have potential applications in various fields, including pharmaceuticals, agrochemicals, and material science, due to its unique structure and properties.

Safety Precautions

It is important to handle this chemical with caution and follow proper safety protocols when working with it.

Upstream product

• 1049684-42-5 C₃₃H₄₄FNO₈P₂ 
• 550998-36-2 3-(3-fluoro-4-methoxyphenyl)-7-hydroxy-1-naphthonitrile 
• 628-13-7 pyridine hydrochloride 
• 158365-53-8 7-methoxy-3,4-dihydronaphthalene-1-carbonitrile 
• 158365-54-9 1-cyano-7-methoxynaphthalene 
• 19307-13-2 7-hydroxy-1-cyanonaphthalene 
• 6836-19-7 7-Methoxy-1-tetralone 
• 550998-30-6 3-bromo-7-hydroxy-1-cyanonaphthalene 

Downstream Products

• 1049684-43-6 C₁₇H₁₂FNO₈P₂ 
• 1049684-44-7 C₁₇H₁₁FNO₅P 
• 1049684-45-8 C₁₇H₁₁FNO₅P 
• 1049684-42-5 C₃₃H₄₄FNO₈P₂ 
• 858946-67-5 7-(tert-butyl-dimethyl-silanyloxy)-3-[4-(tert-butyl-dimethyl-silanyloxy)-3-fluoro-phenyl]-1-(2,2-dibromo-vinyl)-naphthalene 
• 858946-68-6 7-(tert-butyl-dimethyl-silanyloxy)-3-[4-(tert-butyl-dimethyl-silanyloxy)-3-fluoro-phenyl]-1-ethynyl-naphthalene 
• 858946-66-4 7-[[tert-butyl(dimethyl)silyl]oxy]-3-(4-[[tert-butyl(dimethyl)silyl]oxy]-3-fluorophenyl)-1-naphthaldehyde 
• 858946-09-5 8-ethynyl-6-(3-fluoro-4-hydroxy-phenyl)-naphthalen-2-ol 
• 858946-05-1 6-(3-fluoro-4-hydroxy-phenyl)-8-vinyl-naphthalen-2-ol 
• 858946-65-3 7-[[tert-butyl(dimethyl)silyl]oxy]-3-(4-[[tert-butyl(dimethyl)silyl]oxy]-3-fluorophenyl)-1-naphthonitrile 

Relevant articles and documents

PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION

The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.

Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile

A process for making a compound of formula I and intermediate compounds thereof, wherein R1 is CN, F or Cl; R2 is H or Br; and R3 and R4 are each independently H or F. The compounds of formula I are useful in th

Substituted phenyl naphthalenes as estrogenic agents

This invention provides estrogen receptor modulators of formula I, having the structure 1wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, are as defined in the specification, or a pharmaceutically acceptable salt thereof.